SE8604839L - Tiazol/4,5c/kinoliner - Google Patents

Tiazol/4,5c/kinoliner

Info

Publication number
SE8604839L
SE8604839L SE8604839A SE8604839A SE8604839L SE 8604839 L SE8604839 L SE 8604839L SE 8604839 A SE8604839 A SE 8604839A SE 8604839 A SE8604839 A SE 8604839A SE 8604839 L SE8604839 L SE 8604839L
Authority
SE
Sweden
Prior art keywords
general formula
phenyl
hydrogen
compounds
lower alkyl
Prior art date
Application number
SE8604839A
Other languages
English (en)
Swedish (sv)
Other versions
SE8604839D0 (sv
Inventor
J Knoll
E Berenyi
K Budai
B Knoll
Z Forts
J Timbr
G Zsila
I Niklya
L Petocz
A Mandi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of SE8604839D0 publication Critical patent/SE8604839D0/xx
Publication of SE8604839L publication Critical patent/SE8604839L/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE8604839A 1985-11-12 1986-11-12 Tiazol/4,5c/kinoliner SE8604839L (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU854304A HU197019B (en) 1985-11-12 1985-11-12 Process for producing thiqzolo (4,5-c) quinoline derivatives and pharmaceuticals comprising same

Publications (2)

Publication Number Publication Date
SE8604839D0 SE8604839D0 (sv) 1986-11-12
SE8604839L true SE8604839L (sv) 1987-05-13

Family

ID=10967593

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8604839A SE8604839L (sv) 1985-11-12 1986-11-12 Tiazol/4,5c/kinoliner

Country Status (24)

Country Link
US (1) US4904669A (xx)
JP (1) JPS62161792A (xx)
CN (1) CN86107754A (xx)
AU (1) AU592384B2 (xx)
BE (1) BE905719A (xx)
BG (1) BG46156A3 (xx)
CH (1) CH670829A5 (xx)
DD (1) DD254202A5 (xx)
DE (1) DE3638563A1 (xx)
DK (1) DK539786A (xx)
ES (1) ES2002543A6 (xx)
FI (1) FI864611A (xx)
FR (1) FR2603588A1 (xx)
GB (1) GB2184117B (xx)
HU (1) HU197019B (xx)
IL (1) IL80611A0 (xx)
IT (1) IT1213379B (xx)
NL (1) NL8602878A (xx)
NO (1) NO864518L (xx)
PL (1) PL148186B1 (xx)
SE (1) SE8604839L (xx)
SU (1) SU1544190A3 (xx)
YU (1) YU192186A (xx)
ZA (1) ZA868583B (xx)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199423B (en) * 1987-04-24 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 3-amino-4-/ethylthio/-quinoline and pharmaceutical compositions comprising such compounds
US6110929A (en) 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
US6677347B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
WO2004096144A2 (en) * 2003-04-28 2004-11-11 3M Innovative Properties Company Compositions and methods for induction of opioid receptors
AU2004266658A1 (en) * 2003-08-12 2005-03-03 3M Innovative Properties Company Hydroxylamine substituted imidazo-containing compounds
KR101106812B1 (ko) * 2003-08-27 2012-01-19 쓰리엠 이노베이티브 프로퍼티즈 컴파니 아릴옥시 및 아릴알킬렌옥시 치환된 이미다조퀴놀린
EP1660026A4 (en) * 2003-09-05 2008-07-16 3M Innovative Properties Co TREATMENT FOR CD5 + B CELL LYMPHOMA
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
JP5043435B2 (ja) * 2003-10-03 2012-10-10 スリーエム イノベイティブ プロパティズ カンパニー アルコキシ置換イミダゾキノリン
US20090075980A1 (en) * 2003-10-03 2009-03-19 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and Analogs Thereof
JP2007511535A (ja) * 2003-11-14 2007-05-10 スリーエム イノベイティブ プロパティズ カンパニー ヒドロキシルアミン置換イミダゾ環化合物
EP1685129A4 (en) 2003-11-14 2008-10-22 3M Innovative Properties Co OXIMSUBSTITUTED IMIDAZORING CONNECTIONS
WO2005051317A2 (en) * 2003-11-25 2005-06-09 3M Innovative Properties Company Substituted imidazo ring systems and methods
US8802853B2 (en) * 2003-12-29 2014-08-12 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
JP2007517044A (ja) * 2003-12-30 2007-06-28 スリーエム イノベイティブ プロパティズ カンパニー イミダゾキノリニル、イミダゾピリジニル、およびイミダゾナフチリジニルスルホンアミド
WO2005094531A2 (en) * 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
US8017779B2 (en) * 2004-06-15 2011-09-13 3M Innovative Properties Company Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
US7897609B2 (en) * 2004-06-18 2011-03-01 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006065280A2 (en) * 2004-06-18 2006-06-22 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
US8026366B2 (en) * 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US20070259881A1 (en) * 2004-06-18 2007-11-08 Dellaria Joseph F Jr Substituted Imidazo Ring Systems and Methods
US20090270443A1 (en) * 2004-09-02 2009-10-29 Doris Stoermer 1-amino imidazo-containing compounds and methods
EP1819364A4 (en) * 2004-12-08 2010-12-29 3M Innovative Properties Co COMPOSITIONS, IMMUNOMODULATORY COMBINATIONS AND ASSOCIATED METHODS
WO2006083440A2 (en) 2004-12-30 2006-08-10 3M Innovative Properties Company Substituted chiral fused [1,2]imidazo[4,5-c] ring compounds
US7943609B2 (en) * 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
CA2597092A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune reponse modifiers
JP2008530252A (ja) * 2005-02-09 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド オキシムおよびヒドロキシルアミンで置換されたチアゾロ［４，５−ｃ］環化合物ならびに方法
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
JP2008535832A (ja) 2005-04-01 2008-09-04 コーリー ファーマシューティカル グループ，インコーポレイテッド ピラゾロピリジン−１，４−ジアミン、およびそのアナログ
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
US7906506B2 (en) * 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
AU2019363569A1 (en) 2018-10-23 2021-04-29 Basf Se Tricyclic pesticidal compounds
CN115427408A (zh) 2020-04-14 2022-12-02 巴斯夫欧洲公司 杀害虫的三环化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024207A (en) * 1978-05-26 1980-01-09 Lepetit Spa New tricyclic ortho-fused heterocyclic compounds
HU196308B (en) * 1985-11-12 1988-11-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions containing 2-methyl-thiazolo/4,5-c/quinoline as active component

Also Published As

Publication number Publication date
PL262346A1 (en) 1988-03-03
FI864611A0 (fi) 1986-11-12
CH670829A5 (xx) 1989-07-14
YU192186A (en) 1988-10-31
IT8622312A0 (it) 1986-11-12
DK539786D0 (da) 1986-11-12
SE8604839D0 (sv) 1986-11-12
NO864518L (no) 1987-05-13
HU197019B (en) 1989-02-28
DD254202A5 (de) 1988-02-17
NL8602878A (nl) 1987-06-01
HUT44260A (en) 1988-02-29
ES2002543A6 (es) 1988-08-16
GB8627043D0 (en) 1986-12-10
DE3638563A1 (de) 1987-06-25
DK539786A (da) 1987-05-13
AU6508986A (en) 1987-05-14
JPS62161792A (ja) 1987-07-17
GB2184117B (en) 1989-10-11
CN86107754A (zh) 1987-08-05
IT1213379B (it) 1989-12-20
PL148186B1 (en) 1989-09-30
IL80611A0 (en) 1987-02-27
BG46156A3 (en) 1989-10-16
NO864518D0 (no) 1986-11-12
FR2603588A1 (fr) 1988-03-11
US4904669A (en) 1990-02-27
AU592384B2 (en) 1990-01-11
SU1544190A3 (ru) 1990-02-15
BE905719A (fr) 1987-05-07
ZA868583B (en) 1987-08-26
GB2184117A (en) 1987-06-17
FI864611A (fi) 1987-05-13

Similar Documents

Publication Publication Date Title
SE8604839L (sv) Tiazol/4,5c/kinoliner
DE19975027I2 (de) 1H-imidazo(4,5c)chinoline und 1H-Imidazo(4,5-c)chinolin-4-amine
PT87700A (pt) Process for the preparation of a new pyrazolopyridine compound
MY100574A (en) 5-substituted-2-cyclopropyl-6, 8-difluoroquinoline derivatives and processes for preparation thereof
PT79819A (en) Process to prepare dihydropiridazinone derivatives its salts and pharmaceutical compositions and intermediate compounds there with
PT81476A (en) Process for the preparation of quinolone carboxylic acid derivatives
HUP9802393A2 (hu) Benzotiazolonszármazékok, alkalmazásuk, az ezeket tartalmazó gyógyszerkészítmények, eljárás a vegyületek előállítására és intermedierjeik
KR900011770A (ko) 신규 벤조 [1,8] 나프티리딘 유도체, 그 제조방법 및 상기 유도체를 함유하는 조성물
ES2056835T3 (es) Derivados de pirido(2,3-d)pirimidina.
IL75987A0 (en) 1,6-naphthyridine derivatives,their preparation and pharmaceutical compositions containing them
ES8801637A1 (es) Un procedimiento para la preparacion de benzimidazoles.
GR70356B (xx)
FR2626279B1 (fr) Nouveaux derives de l'indolo(3,2,1-de)(1,4)-oxazino(2,3,4-ij)(1,5) naphthyridine, leur procede de preparation et les nouveaux intermediaires ainsi obtenus, leur application comme medicaments et les compositions les renfermant
PT84172A (pt) Process for the preparation of quinoleine derivatives
IL59358A (en) Hydroxytetrahydro(phenoxymethyl)-imidazothiazole and thiazolopyrimidine derivatives,their preparation and pharmaceutical compositions containing them
ATE67197T1 (de) Thiadiazinon-derivate.
IL97611A (en) Heterocyclic compounds, their preparation and pharmaceutical compositions containing them
ES2002111A6 (es) Un procedimiento para preparar pirimido-(2,1-b)-benzotiazoles
ES8105286A1 (es) Un procedimiento para la preparacion de nuevos derivados de dihidropiridina.
SE8405332D0 (sv) 2h-azeto(2,1-a)-isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
TH4681A (th) กรรมวิธีสำหรับเตรียมสารไธแอโซโล (4, 5-c) ควิโนลีน
TH4681EX (th) กรรมวิธีสำหรับเตรียมสารไธแอโซโล (4, 5-c) ควิโนลีน

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8604839-4

Effective date: 19901115

Format of ref document f/p: F